Radiomic signatures associated with tumor immune heterogeneity predict survival in locally recurrent nasopharyngeal carcinoma
Lin, Da-Feng13,14,15,16,17; Li, Hai-Lin11,12; Liu, Ting10,13,14,15,16,17; Lv, Xiao-Fei9,13,14,15,16; Xie, Chuan-Miao9,13,14,15,16; Ou, Xiao-Min7,8; Guan, Jian6; Zhang, Ye5; Yan, Wen-Bin7,8; He, Mei-Lin
刊名JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
2024-04-19
页码10
ISSN号0027-8874
DOI10.1093/jnci/djae081
通讯作者Tang, Lin-Quan(tanglq@sysucc.org.cn)
英文摘要Background The prognostic value of traditional clinical indicators for locally recurrent nasopharyngeal carcinoma is limited because of their inability to reflect intratumor heterogeneity. We aimed to develop a radiomic signature to reveal tumor immune heterogeneity and predict survival in locally recurrent nasopharyngeal carcinoma.Methods This multicenter, retrospective study included 921 patients with locally recurrent nasopharyngeal carcinoma. A machine learning signature and nomogram based on pretreatment magnetic resonance imaging features were developed for predicting overall survival in a training cohort and validated in 2 independent cohorts. A clinical nomogram and an integrated nomogram were constructed for comparison. Nomogram performance was evaluated by concordance index and receiver operating characteristic curve analysis. Accordingly, patients were classified into risk groups. The biological characteristics and immune infiltration of the signature were explored by RNA-sequencing analysis.Results The machine learning signature and nomogram demonstrated comparable prognostic ability to a clinical nomogram, achieving concordance indexes of 0.729, 0.718, and 0.731 in the training, internal, and external validation cohorts, respectively. Integration of the signature and clinical variables statistically improved the predictive performance. The proposed signature effectively distinguished patients between risk groups with statistically distinct overall survival rates. Subgroup analysis indicated the recommendation of local salvage treatments for low-risk patients. Exploratory RNA-sequencing analysis revealed differences in interferon response and lymphocyte infiltration between risk groups.Conclusions A magnetic resonance imaging-based radiomic signature predicted overall survival more accurately. The proposed signature associated with tumor immune heterogeneity may serve as a valuable tool to facilitate prognostic stratification and guide individualized management for locally recurrent nasopharyngeal carcinoma patients.
资助项目National Key Research and Development Program of China ; Institute of Automation, Chinese Academy of Sciences (Beijing, China)
WOS关键词INTENSITY-MODULATED RADIOTHERAPY ; 1ST-LINE TREATMENT ; PROGNOSTIC-FACTORS ; PLUS CHEMOTHERAPY ; CLINICAL-RESPONSE ; OPEN-LABEL ; MULTICENTER ; CANCER ; MODEL
WOS研究方向Oncology
语种英语
出版者OXFORD UNIV PRESS INC
WOS记录号WOS:001228741800001
资助机构National Key Research and Development Program of China ; Institute of Automation, Chinese Academy of Sciences (Beijing, China)
内容类型期刊论文
源URL[http://ir.ia.ac.cn/handle/173211/58430]  
专题自动化研究所_中国科学院分子影像重点实验室
通讯作者Tang, Lin-Quan
作者单位1.Natl Key Lab Kidney Dis, Beijing, Peoples R China
2.Sun Yat Sen Univ, Canc Ctr, Dept VIP Inpatient, Guangzhou, Peoples R China
3.Jinan Univ, Affiliated Hosp 1, Dept Oncol, Guangzhou, Peoples R China
4.Univ Chinese Acad Sci, Sch Artificial Intelligence, Beijing, Peoples R China
5.Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Radiat Oncol,Natl Canc Ctr, Beijing, Peoples R China
6.Southern Med Univ, Nanfang Hosp, Dept Radiat Oncol, Guangzhou, Peoples R China
7.Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China
8.Fudan Univ, Shanghai Canc Ctr, Dept Radiat Oncol, Shanghai, Peoples R China
9.Sun Yat Sen Univ, Canc Ctr, Dept Radiol, Guangzhou, Peoples R China
10.Sun Yat Sen Univ, Affiliated Hosp 1, Breast Dis Ctr, Dept Breast Surg, Guangzhou, Peoples R China
推荐引用方式
GB/T 7714
Lin, Da-Feng,Li, Hai-Lin,Liu, Ting,et al. Radiomic signatures associated with tumor immune heterogeneity predict survival in locally recurrent nasopharyngeal carcinoma[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE,2024:10.
APA Lin, Da-Feng.,Li, Hai-Lin.,Liu, Ting.,Lv, Xiao-Fei.,Xie, Chuan-Miao.,...&Dong, Di.(2024).Radiomic signatures associated with tumor immune heterogeneity predict survival in locally recurrent nasopharyngeal carcinoma.JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE,10.
MLA Lin, Da-Feng,et al."Radiomic signatures associated with tumor immune heterogeneity predict survival in locally recurrent nasopharyngeal carcinoma".JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2024):10.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace